RNID: For deaf and hard of hearing people.

Today's cochlear implant market is dominated by three global manufacturers; Cochlear Ltd, Advanced Bionics Corporation and Med-El Corporation who all use similar technology. They also manufacture in small volumes by hand, an expense passed on to public healthcare providers. This high cost, typically around $25,000, is a major factor in limiting the number of people benefiting from this life-changing device.

Our market research shows that such a device would enjoy considerable commercial success whilst benefiting people who may not have had access to it previously.

Dr Ralph Holme, Head of Biomedical Research at RNID, says: "There is a gap in the market for a medical device company to produce a low-cost implant by using more cost-efficient manufacturing practices. Our market research shows that such a device would enjoy considerable commercial success whilst benefiting people who may not have had access to it previously."
 
RNID will be participating at the BioDevice Partnering conference in Zurich, Switzerland (12-13 June 2007) to raise awareness and highlight this opportunity to the Medical Device industry.